23.90
-0.70
(-2.85%)
At close: 2:59:44 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,699.00
-29,699.00
-41,329.00
-22,995.00
-17,736.00
Investing Cash Flow
48,152.00
48,152.00
-45,009.00
-118,067.00
24,180.00
Financing Cash Flow
295,846.00
295,846.00
-20,655.00
281,819.00
-10,216.00
End Cash Position
399,458.00
399,458.00
85,159.00
192,152.00
51,395.00
Capital Expenditure
-6,678.00
-6,678.00
-4,248.00
-7,522.00
-7,528.00
Issuance of Capital Stock
311,600.00
311,600.00
--
300,000.00
1,225.00
Free Cash Flow
-36,377.00
-36,377.00
-45,577.00
-30,517.00
-25,264.00
12/31/2020 - 6/16/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6704.TWO Gwo Xi Stem Cell Applied Technology Co. , Ltd
27.50
+0.36%
6580.TWO TaiRx, Inc.
26.45
+1.73%
4197.TWO Visgeneer Inc.
9.78
0.00%
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
8.35
+4.64%
4732.TWO NatureWise Biotech & Medicals Corporation
22.95
-1.08%
6709.TWO Advagene Biopharma Co., Ltd.
20.40
+0.74%
4170.TWO VBI
13.90
-1.42%
7808.TWO BIONET TX Corp
45.85
-0.33%
6586.TWO CHO Pharma, Inc.
50.90
0.00%
6748.TWO ACRO Biomedical Co., Ltd.
24.45
-1.41%